Abivax SA
PAR:ABVX

Watchlist Manager
Abivax SA Logo
Abivax SA
PAR:ABVX
Watchlist
Price: 94.1 EUR -9.69% Market Closed
Market Cap: 7.3B EUR

Operating Margin
Abivax SA

0%
Current
0%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-220m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Abivax SA
PAR:ABVX
7.3B EUR N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
395.3B USD
33%
US
Amgen Inc
NASDAQ:AMGN
175.8B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
147.5B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.6B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.6B USD
28%
AU
CSL Ltd
ASX:CSL
83.8B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.6B USD
8%
NL
argenx SE
XBRU:ARGX
44.4B EUR
22%
No Stocks Found

Abivax SA
Glance View

Market Cap
7.3B EUR
Industry
Biotechnology

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

ABVX Intrinsic Value
12.95 EUR
Overvaluation 86%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-220m
/
Revenue
0
What is the Operating Margin of Abivax SA?

Based on Abivax SA's most recent financial statements, the company has Operating Margin of 0%.

Back to Top